Phylos Bioscience is trying to prevent Monsanto from corrupting the marijuana industry.
Last year in August, federal officials silently approved a patent for a strain of THC-potent cannabis.
Marijuana legalization is seeing huge changes in the right direction right after the current election. Although, a lot of people are concerned that this has opened the door for companies like Monsanto to eliminate any of its competitors with patents.
Only 20% of America has legalized marijuana for recreational use, and this number will only increase as corporate interest does. In Portland, and independent starter-up is in the process of making marijuana’s genome available to the public to reduce the impact from patents and to prevent the plant’s genome from being exploited by corporations like Monsanto.
In the past two years alone, Phylos Bioscience has accrued a variety of samples from different strains of marijuana, which allowed the DNA sequence in each strain to startup.
Phylos Bioscience’s Galaxy could bring stability into the marijuana industry, which is starting to bloom into a commercial market open to the public.
Sample collection was a huge part of this process. One side was a collaboration with growers, dispensaries and labs to collect modern samples, and the other a process of hunting down ancient landrace strains from all over the world.
Thankfully, we have many on our side who want to protect marijuana from corporations that want to exploit it for corporate greed.
If you enjoyed this article or learned something new, please don’t forget to share it with others so they have a chance to enjoy this free information. We believe all information should be free and available to everyone. Have a good day and we hope to see you soon!